News Website

Study Misses Endpoints but Still Shows Benefit for Lenvatinib/Pembrolizumab in Endometrial Cancer Subsets - The ASCO Post

Study Misses Endpoints but Still Shows Benefit for Lenvatinib/Pembrolizumab in Endometrial Cancer Subsets The ASCO Post

Published: June 10, 2024, 7 a.m.

Read Full Article

Endometriosis increases risks for ovarian, endometrial cancers - Healio

Endometriosis increases risks for ovarian, endometrial cancers Healio

Published: June 7, 2024, 7 a.m.

Read Full Article

ASCO Reading Room | Sound Evidence to Treat Smaller, Recurrent Endometrial Cancers With Radiotherapy Alone - Medpage Today

ASCO Reading Room | Sound Evidence to Treat Smaller, Recurrent Endometrial Cancers With Radiotherapy Alone Medpage Today

Published: June 5, 2024, 7 a.m.

Read Full Article

Leading Cancer Researchers from NYU Langone’s Perlmutter Cancer Center Present Latest Clinical Findings & Research at ASCO 2024 Annual Conference - NYU Langone Health

Leading Cancer Researchers from NYU Langone’s Perlmutter Cancer Center Present Latest Clinical Findings & Research at ASCO 2024 Annual Conference NYU Langone Health

Published: June 3, 2024, 7 a.m.

Read Full Article

Integrating proteomics and explainable artificial intelligence: a comprehensive analysis of protein biomarkers for endometrial cancer diagnosis and prognosis - Frontiers

Integrating proteomics and explainable artificial intelligence: a comprehensive analysis of protein biomarkers for endometrial cancer diagnosis and prognosis Frontiers

Published: June 2, 2024, 7 a.m.

Read Full Article

Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates - PR Newswire

Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates PR Newswire

Published: June 1, 2024, 7 a.m.

Read Full Article

Construction and validation of a clinical risk model based on machine learning for screening characteristic factors of lymphovascular space invasion in endometrial cancer - Nature.com

Construction and validation of a clinical risk model based on machine learning for screening characteristic factors of lymphovascular space invasion in endometrial cancer Nature.com

Published: June 1, 2024, 7 a.m.

Read Full Article

Comparative Analysis of Shapley Values Enhances Transcriptomics Insights across Some Common Uterine Pathologies.

Uterine pathologies pose a challenge to women's health on a global scale. Despite extensive research, the causes and origin of some of these common disorders are not well defined yet. …

Published: June 1, 2024, midnight

Read Full Article

endometrial cancer endometriosis microarrays systems biology transcriptomics uterine leiomyomas

FDA grants breakthrough designation for ovarian cancer liquid biopsy - TechTarget

FDA grants breakthrough designation for ovarian cancer liquid biopsy TechTarget

Published: May 31, 2024, 7 a.m.

Read Full Article

Deep learning to assess microsatellite instability directly from histopathological whole slide images in endometrial cancer | npj Digital Medicine - Nature.com

Deep learning to assess microsatellite instability directly from histopathological whole slide images in endometrial cancer | npj Digital Medicine Nature.com

Published: May 29, 2024, 7 a.m.

Read Full Article

Latest Articles

Study Misses Endpoints but Still Shows Benefit for Lenvatinib/Pembrolizumab in Endometrial Cancer Subsets - The ASCO Post

Endometriosis increases risks for ovarian, endometrial cancers - Healio

ASCO Reading Room | Sound Evidence to Treat Smaller, Recurrent Endometrial Cancers With Radiotherapy Alone - Medpage Today

Leading Cancer Researchers from NYU Langone’s Perlmutter Cancer Center Present Latest Clinical Findings & Research at ASCO 2024 Annual Conference - NYU Langone Health

Integrating proteomics and explainable artificial intelligence: a comprehensive analysis of protein biomarkers for endometrial cancer diagnosis and prognosis - Frontiers

Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates - PR Newswire

Construction and validation of a clinical risk model based on machine learning for screening characteristic factors of lymphovascular space invasion in endometrial cancer - Nature.com

Comparative Analysis of Shapley Values Enhances Transcriptomics Insights across Some Common Uterine Pathologies.

FDA grants breakthrough designation for ovarian cancer liquid biopsy - TechTarget

Deep learning to assess microsatellite instability directly from histopathological whole slide images in endometrial cancer | npj Digital Medicine - Nature.com

Subscribe to Our Newsletter